En vigueur

Tramadol excretion study administered orally for the improvement of detection of these substances in anti-doping controls (analytical part)

Investigateur principal
R. Ventura
Pays
Espagne
Institution
Institut Municipal d’Investigacio Medica (IMIM)
Année approuvée
2022
Statut
En vigueur

Description du projet

Code: T22M01RTRV - Part 2

12 hours starting from any dose”, which is considered as the cut-off between maximal therapeutic dosagesfor athletes benefiting from a therapeutic use exemption and doses at which a doping effect could begin to be expected from systemic exposure [8]. The WADA established a urinary concentration